The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
OBJECTIVE
To describe the use of postoperative topical mitomycin C (MMC) in the treatment of recurrent conjunctival papilloma.


METHODS
Case report.


RESULTS
We report a 26-year-old man with recurrent conjunctival papilloma despite repeated surgical excision, cauterization, and cryotherapy. He was then treated with excision by cryotherapy, followed by a 2-week course of topical MMC eyedrops prescribed at postoperative day 7 (0.02 mg/mL, four times daily). No recurrence was observed 24 months postoperatively, and no complication was observed during the follow-up period.


CONCLUSIONS
Postoperative topical MMC may be a useful adjunct in the management of recurrent conjunctival papilloma.
Yuen
Hunter K L
HK
Hong Kong Eye Hospital, Hospital Authority Ophthalmic Services, Hong Kong, People's Republic of China.
Yeung
Emily F Y
EF
Chan
Nongnart R
NR
Chi
Stanley C C
SC
Lam
Dennis S C
DS
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D003228:Conjunctiva / Q000187:drug effects / Q000473:pathology; D003230:Conjunctival Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D010212:Papilloma / Q000188:drug therapy* / Q000473:pathology; D011184:Postoperative Period; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D009883:Ophthalmic Solutions; D016685:Mitomycin